Health and Aging

Women's Health and Menopause offers info on quitting smoking for older adults

The National Institutes of Health has released a new Web resource to help older adults stop smoking. Quitting Smoking for Older Adults, a new topic from NIHSeniorHealth, offers videos, worksheets, interactive features, strategies, quizzes, and more for older smokers who want to or are thinking of quitting.

NIH urges older Americans to protect their kidneys

In recognition of World Kidney Day 2014 on March 13, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Institute on Aging (NIA) at the National Institutes of Health remind older Americans about the importance of protecting their kidneys and urge them to better understand the decline of kidney function as people age.

Estrogen therapy has no long-term effect on cognition in younger postmenopausal women

A randomized clinical trial of estrogen therapy in younger postmenopausal women, aged 50–55, has found no long-term risk or benefit to cognitive function. The National Institutes of Health-supported study, reported in JAMA Internal Medicine on June 24, 2013, looked at women taking conjugated equine estrogens, the most common type of postmenopausal hormone therapy in the United States.

The earlier Women’s Health Initiative Memory Study (WHIMS) linked the same type of hormone therapy to cognitive decline and dementia in older postmenopausal women.

Menopause: Time for a Change


What can a woman expect before, during, and after her last period? This 37-page booklet discusses menopause, hot flashes, and other menopausal symptoms. It also includes what women can do to stay healthy after menopause.

Urinary Incontinence


Urinary incontinence can happen to both men and women and is more common in older people. Learn about the condition and how to manage it.


NIA supports studies of health needs of LGBT community

As the American population ages, the number of lesbian, gay, bisexual, and transgender (LGBT) individuals ages 65 and older is also increasing. However, we know surprisingly little about unique health issues and needs that may pertain to this group. Much of the data available are based on small studies and are not nationally representative.

NIH researchers find gene affects fertility in mice

Increasing activity of a single gene--FOXO3--increases fertility by 31 to 49 percent in female mice, report researchers at the National Institute on Aging, NIH. Variants of the FOXO3 gene have been previously associated with longevity in many animal models, including humans; but, in mice the main effect of loss or increase of FOXO3 is on ovary function.

CDC recommends that all baby boomers get hepatitis C test

The CDC has issued new guidelines for hepatitis C testing, focusing on people born during 1945–1965, a population with a disproportionately high prevalence of HCV infection and related disease. CDC is now recommending all baby boomers receive a one-time hepatitis C test. “A one-time blood test for hepatitis C should be on every baby boomer’s medical checklist,” said CDC Director Thomas R. Frieden, M.D., M.P.H. “The new recommendations can protect the health of an entire generation of Americans and save thousands of lives.”

El abuso de las personas mayores


Gerardo, de 73 años de edad, sufrió un ataque (derrame) cerebral. Como no podía cuidarse a sí mismo, se pasó a vivir con la familia de su hijo. Su hijo trató de ayudar, pero era Frida, su nuera, la que usualmente cocinaba comidas especiales y le ayudaba a bañarse y a vestirse. Frida ya estaba suficientemente ocupada atendiendo a dos muchachos adolescentes y trabajando como maestra de tercer grado. Al principio, todos estaban contentos de que Gerardo estuviera viviendo con la familia.

Media Availability: NIH-supported trial finds antidepressant relieves hot flashes

WHAT: A randomized clinical trial supported by the National Institutes of Health (NIH) has found that the antidepressant escitalopram (Lexapro) significantly reduced the number and severity of hot flashes eight weeks after beginning treatment. In this trial comparing escitalopram to placebo, the treatment group experienced a 47 percent decrease in daily hot flashes, while the placebo group had a 33 percent decrease. Reductions in severity and bothersomeness of hot flashes were also reported by the treatment group.

Subscribe to RSS - Women's Health and Menopause